New England Biolabs Continues Microbial Fermentation Partnership with ABEC
ABEC, a global provider of engineered solutions and services for biotech manufacturing, today announced it is delivering multiple 40L stainless steel fermenters to New England Biolabs® (NEB®), further supporting their high-density fermentation of recombinant Escherichia coli and Pichia pastoris. NEB has again selected ABEC based on the recent successful delivery of 400L and 1,000L stainless steel fermenters to their manufacturing facilities in Ipswich and Rowley, MA.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220504005176/en/
The 40L fermenters will replicate the larger scale ABEC fermenters in both design and performance, allowing NEB to conduct multidimensional experimental studies to optimize their fermentation processes. NEB, a global supplier-of-choice for scientific researchers, produces over 500 proteins for research and IVD markets. ABEC’s customized approach and ability to deliver high-quality, reliable fermenters are key to supporting NEB in providing advanced proteins to the scientific community while meeting the highest standards of product quality.
“ABEC’s 40L fermenters will allow New England Biolabs to facilitate a seamless transition from development to production,” said Maurice Southworth, Executive Director of Production at New England Biolabs. “ABEC’s ongoing support enables us to increase our fermentation capabilities as we continue to expand our product offerings into new areas of research.”
“We look forward to continuing our fermentation partnership with New England Biolabs,” said Scott Pickering, ABEC CEO and Chairman. “We appreciate their trust and confidence and remain committed to supporting their success.”
About ABEC
Since 1974, ABEC has been a global leader in delivering engineered process solutions and services for manufacturing in the biotech industry. The majority of the world's pharmaceutical and biotech companies are ABEC customers; with many of today's leading therapies manufactured by processes and equipment engineered, manufactured, installed and serviced by ABEC. ABEC's unique value is based on long experience, complete in-house capabilities, a custom, flexible approach, and long-term credibility. Whether adding capacity or improving existing facilities, ABEC's turn-key solutions and support services reduce overall cost and time to market while delivering maximum productivity. To learn more about ABEC, visit abec.com, email info@abec.com and follow us on LinkedIn.
About New England Biolabs
Established in the mid 1970’s, New England Biolabs, Inc. (NEB) is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, synthetic biology, glycobiology, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors, including molecular diagnostics development. New England Biolabs is a privately held company, headquartered in Ipswich, MA, and has extensive worldwide distribution through a network of exclusive distributors, agents and eight subsidiaries located in Australia, Canada, China, France, Germany, Japan, Singapore and the UK. For more information about New England Biolabs visit www.neb.com. NEB® and NEW ENGLAND BIOLABS® are registered trademarks of New England Biolabs, Inc.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220504005176/en/
Contact information
Media:
Susan Cooper-Curcio, Director of Marketing, +1 (610) 861 4666, scurcio@abec.com
Deana D. Martin, Ph.D. Associate Director, Marketing Communications, +1 (978) 380-7464, martin@neb.com
About Business Wire
Business WireSubscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Everen Declares $200 Million Dividend and Welcomes New Chief Operating Officer27.3.2023 22:59:00 CEST | Press release
Everen Limited (Everen) held its March 2023 Board Meeting on Tuesday, March 21st and its Annual General Meeting (AGM) on Thursday, March 23rd. During the Board Meeting, the directors approved Everen’s 2022 financial statements, discussed the ongoing execution of the 5-year Strategic Plan, and declared a dividend in the aggregate amount of $200 million payable on or before September 29, 2023 to shareholders of record on March 21, 2023. During the AGM, the Shareholders approved technical wording corrections to the Eligibility Requirements and definition of a Nuclear Facility and amended Everen’s Bye-Laws to resolve inconsistencies and elements not required by the Bermuda Companies Act 1981. They also elected a new Board of Directors who will serve for a year ending at the March 2024 AGM. The Shareholders recognized Gail Miller (VP, Human Resources) for her 18 years of service and significant contributions to the organization and also welcomed Robert Foskey into the role of Chief Operatin
Co-Founder John Keppler Rejoins Enviva Inc. as Executive Chairman of the Board27.3.2023 22:46:00 CEST | Press release
Enviva Inc. (NYSE: EVA) (“Enviva,” “our,” “we,” or the “Company”) today announced that John Keppler is returning to the Company as Executive Chairman, effective April 1, 2023. Thomas Meth will continue to lead the Company as President and Chief Executive Officer, and the Company’s interim Chairman, Ralph Alexander, will transition to the role of Lead Independent Director of the Board. Today’s announcement is consistent with the Board of Directors’ (the “Board”) governance plan as announced in November 2022, when Mr. Keppler stepped down from his role as Chairman and CEO of Enviva to address a heart condition. With Mr. Keppler’s recovery and rehabilitation following heart surgery well underway, he is returning to the Company to support his co-founding partner and CEO, Thomas Meth. As Executive Chairman, in cooperation with Mr. Meth, Mr. Keppler is expected to help drive strategic corporate initiatives, growth, and interaction with key capital markets and financial stakeholders. “I am ve
French Blood Establishment (EFS) & Brenus Pharma Partner for the GMP Production of STC-1010, an Innovative Therapy Against Colorectal Cancer27.3.2023 18:00:00 CEST | Press release
The French Blood Establishment (EFS) and Brenus Pharma announce their strategic partnership in the bioproduction of innovative therapy drugs (ITD), highlighting French expertise. This collaboration is part of a shared vision: developing the French bioproduction sector nationally and internationally. EFS’ Cell Therapy and Engineering Unit (UTICELL), based in Saint-Ismier, France, shows recognized expertise in the cell therapy field since 2003 confirmed by a European GMP Certification issued by the ANSM in 2015 for manufacturing, control and storage sites for MTIs. UTICELL also benefits from EFS’ four other certified sites’ expertise. Brenus’s proprietary platform passed key regulatory milestones in 2022 (FDA Pre-IND, EMA Scientific-Advice) and the two synergistic entities have been collaborating effectively for several months to produce GMPs batches through a first scale-up. This public-private partnership aims for a long-term perspective and will lead in 2023 to the production of clini
ETC Group Unveils New Future-Forward Global Brand27.3.2023 17:15:00 CEST | Press release
ETC Group (“ETC”), a leading global value-added distributor for the telecom network and digital infrastructure industry, announced today its intent to rebrand to Netceed. The Group’s brands will integrate into a singular organization across the globe including USTC Corp, Walker, Comstar Supply, and Multicom in the U.S.; EuroTechnoCom in France; ETCP and iETC in Portugal; Comtec in the UK, Qatar, Oman, UAE, and Hong Kong; ILDC in Israel; DNT in the Dominican Republic; ETC Morocco Networks; ETC Germany Networks; Klonex-VCS in Poland; and Tiba Produktions & Vertriebs GmbH in Austria. The unification of the Group reflects the already well-established global reach and local expertise of the companies powered by ETC Group, now coalescing them under one brand worldwide. The transition to the unified global Netceed brand is planned sequentially over six months, starting with its brands in the U.S., France, and the UK. The new name, Netceed, paired with a bold and vibrant new brand design embod
Africell Angola Races Towards 10 Million Subscribers Using Csmart Digital BSS Platform27.3.2023 16:21:00 CEST | Press release
Within 8 months of launching services in Angola, Africell already has over 7 million subscribers. To achieve such rapid progress, Africell needed a new-age digital solution that would help execute its market timelines and provide reliable services across its expanding Angola footprint. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230326005092/en/ Africell’s vision of bringing new products to market which make a positive difference to customers has been facilitated by Csmart, a digital BSS platform built to meet the growth requirements of innovative telecoms players like Africell. The solution - which is built on TM Forum’s ODA and Open API standards - helps customers monetize any business model, network, service, and experience at scale. “We are committed to delivering on Africell’s vision of affordability, reliability and customer experience,” says CEO of Covalense Digital, Sreenivas Peesapati, adding that “Csmart would c
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom